Literature DB >> 24127073

A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients.

Imen Ben-Mustapha1, Meriem Ben-Ali, Najla Mekki, Etienne Patin, Christine Harmant, Jihène Bouguila, Houda Elloumi-Zghal, Abdelaziz Harbi, Mohamed Béjaoui, Lamia Boughammoura, Jalel Chemli, Mohamed-Ridha Barbouche.   

Abstract

Mendelian susceptibility to mycobacterial disease (MSMD) is a rare disorder predisposing apparently healthy individuals to infections caused by weakly virulent mycobacteria such as bacille Calmette-Guerin (BCG), environmental mycobacteria, and poorly virulent Salmonella strains. IL-12p40 deficiency is the first reported human disease due to a cytokine gene defect and is one of the deficiencies that cause MSMD. Nine mutant alleles only have been identified in the IL12B gene, and three of them are recurrent mutations due to a founder effect in specific populations. IL-12p40 deficiency has been identified especially in countries where consanguinity is high and where BCG vaccination at birth is universal. We investigated, in such settings, the clinical, cellular, and molecular features of six IL-12p40-deficient Tunisian patients having the same mutation in IL12B gene (c.298_305del). We found that this mutation is inherited as a common founder mutation arousing ~1,100 years ago. This finding facilitates the development of a preventive approach by genetic counseling and prenatal diagnosis especially in affected families.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24127073     DOI: 10.1007/s00251-013-0739-0

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  25 in total

1.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease.

Authors:  Jacinta Bustamante; Andres A Arias; Guillaume Vogt; Capucine Picard; Lizbeth Blancas Galicia; Carolina Prando; Audrey V Grant; Christophe C Marchal; Marjorie Hubeau; Ariane Chapgier; Ludovic de Beaucoudrey; Anne Puel; Jacqueline Feinberg; Ethan Valinetz; Lucile Jannière; Céline Besse; Anne Boland; Jean-Marie Brisseau; Stéphane Blanche; Olivier Lortholary; Claire Fieschi; Jean-François Emile; Stéphanie Boisson-Dupuis; Saleh Al-Muhsen; Bruce Woda; Peter E Newburger; Antonio Condino-Neto; Mary C Dinauer; Laurent Abel; Jean-Laurent Casanova
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Estimating the age of rare disease mutations: the example of Triple-A syndrome.

Authors:  E Genin; A Tullio-Pelet; F Begeot; S Lyonnet; L Abel
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

3.  Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat.

Authors:  B Brinkmann; M Klintschar; F Neuhuber; J Hühne; B Rolf
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Authors:  Anne Puel; Sophie Cypowyj; Jacinta Bustamante; Jill F Wright; Luyan Liu; Hye Kyung Lim; Mélanie Migaud; Laura Israel; Maya Chrabieh; Magali Audry; Matthew Gumbleton; Antoine Toulon; Christine Bodemer; Jamila El-Baghdadi; Matthew Whitters; Theresa Paradis; Jonathan Brooks; Mary Collins; Neil M Wolfman; Saleh Al-Muhsen; Miguel Galicchio; Laurent Abel; Capucine Picard; Jean-Laurent Casanova
Journal:  Science       Date:  2011-02-24       Impact factor: 47.728

5.  Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.

Authors:  Houda Elloumi-Zghal; Mohamed Ridha Barbouche; Jalel Chemli; Mohamed Béjaoui; Abdelaziz Harbi; Noureddine Snoussi; Sonia Abdelhak; Koussay Dellagi
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

6.  Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.

Authors:  Monia Ouederni; Quentin B Vincent; Pierre Frange; Fabien Touzot; Sami Scerra; Mohamed Bejaoui; Aziz Bousfiha; Yves Levy; Barbara Lisowska-Grospierre; Danielle Canioni; Julie Bruneau; Marianne Debré; Stéphane Blanche; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

7.  Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.

Authors:  Calman MacLennan; Claire Fieschi; David A Lammas; Capucine Picard; Susan E Dorman; Ozden Sanal; Jenny M MacLennan; Steven M Holland; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

8.  Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation.

Authors:  Karin R Engelhardt; Neil Shah; Intan Faizura-Yeop; Dilara F Kocacik Uygun; Natalie Frede; Aleixo M Muise; Eyal Shteyer; Serkan Filiz; Ronnie Chee; Mamoun Elawad; Britta Hartmann; Peter D Arkwright; Christopher Dvorak; Christoph Klein; Jennifer M Puck; Bodo Grimbacher; Erik-Oliver Glocker
Journal:  J Allergy Clin Immunol       Date:  2012-11-14       Impact factor: 10.793

9.  Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

Authors:  F Altare; D Lammas; P Revy; E Jouanguy; R Döffinger; S Lamhamedi; P Drysdale; D Scheel-Toellner; J Girdlestone; P Darbyshire; M Wadhwa; H Dockrell; M Salmon; A Fischer; A Durandy; J L Casanova; D S Kumararatne
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.

Authors:  Dusan Bogunovic; Minji Byun; Larissa A Durfee; Avinash Abhyankar; Ozden Sanal; Davood Mansouri; Sandra Salem; Irena Radovanovic; Audrey V Grant; Parisa Adimi; Nahal Mansouri; Satoshi Okada; Vanessa L Bryant; Xiao-Fei Kong; Alexandra Kreins; Marcela Moncada Velez; Bertrand Boisson; Soheila Khalilzadeh; Ugur Ozcelik; Ilad Alavi Darazam; John W Schoggins; Charles M Rice; Saleh Al-Muhsen; Marcel Behr; Guillaume Vogt; Anne Puel; Jacinta Bustamante; Philippe Gros; Jon M Huibregtse; Laurent Abel; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Science       Date:  2012-08-02       Impact factor: 47.728

View more
  6 in total

Review 1.  Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Semin Immunol       Date:  2014-10-26       Impact factor: 11.130

2.  Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia.

Authors:  Abdulrahman N Alodayani; Abdulnasir M Al-Otaibi; Caroline Deswarte; Husn Habib Frayha; Matthieu Bouaziz; Maryam AlHelale; Tom Le Voyer; Alejandro Nieto-Patlan; Vimel Rattina; Mofareh AlZahrani; Rabih Halwani; Fahad Al Sohime; Hamoud Al-Mousa; Saleh Al-Muhsen; Sami H Alhajjar; Nabil S Dhayhi; Laurent Abel; Jean-Laurent Casanova; Ibrahim Bin-Hussain; May S AlBarrak; Suliman A Al-Jumaah; Jacinta Bustamante
Journal:  J Clin Immunol       Date:  2018-03-27       Impact factor: 8.317

3.  A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.

Authors:  Khaoula Ben-Farhat; Imen Ben-Mustapha; Meriem Ben-Ali; Karen Rouault; Saber Hamami; Najla Mekki; Amel Ben-Chehida; Beya Larguèche; Zohra Fitouri; Selim Abdelmoula; Monia Khemiri; Mohamed-Neji Guediche; Samir Boukthir; Sihem Barsaoui; Jalel Chemli; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2016-05-25       Impact factor: 8.317

4.  Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.

Authors:  Hanen Ouadani; Imen Ben-Mustapha; Meriem Ben-ali; Leila Ben-khemis; Beya Larguèche; Raoudha Boussoffara; Sonia Maalej; Ilhem Fetni; Saida Hassayoun; Abdelmajid Mahfoudh; Fethi Mellouli; Sadok Yalaoui; Hatem Masmoudi; Mohamed Bejaoui; Mohamed-Ridha Barbouche
Journal:  Immunogenetics       Date:  2015-11-06       Impact factor: 2.846

Review 5.  Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.

Authors:  Mohamed-Ridha Barbouche; Najla Mekki; Meriem Ben-Ali; Imen Ben-Mustapha
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

6.  Genetics and genomic medicine in Tunisia.

Authors:  Houda Elloumi-Zghal; Habiba Chaabouni Bouhamed
Journal:  Mol Genet Genomic Med       Date:  2018-03       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.